ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Enveric Biosciences Inc

Enveric Biosciences Inc (ENVB)

0.8199
0.0033
(0.40%)
Closed May 25 4:00PM
0.8101
-0.0098
(-1.20%)
After Hours: 7:31PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.8101
Bid
0.81
Ask
0.8599
Volume
70,334
0.80 Day's Range 0.8315
0.649 52 Week Range 6.98
Market Cap
Previous Close
0.8166
Open
0.8315
Last Trade Time
Financial Volume
$ 57,032
VWAP
0.810874
Average Volume (3m)
1,782,215
Shares Outstanding
2,321,315
Dividend Yield
-
PE Ratio
-0.11
Earnings Per Share (EPS)
-7.52
Revenue
-
Net Profit
-17.46M

About Enveric Biosciences Inc

Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline include... Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Enveric Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENVB. The last closing price for Enveric Biosciences was $0.82. Over the last year, Enveric Biosciences shares have traded in a share price range of $ 0.649 to $ 6.98.

Enveric Biosciences currently has 2,321,315 shares outstanding. The market capitalization of Enveric Biosciences is $1.86 million. Enveric Biosciences has a price to earnings ratio (PE ratio) of -0.11.

ENVB Latest News

Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results

Revealed seven classes of promising novel drug candidates discovered using Enveric’s Psybrary™ and PsyAI™ drug discovery and artificial intelligence (AI) platforms Launched business development...

Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders

MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds Enveric Biosciences...

Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids

Biotechnology licensee expected to progress methods targeting breast and other cancers using cannabinoids in combination with chemotherapeutic drugs Enveric Biosciences, Inc (NASDAQ: ENVB), a...

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023

Product Development Highlights: Selected neuroplastogen lead candidate EB-003, a potential first-in-class therapeutic option for addressing difficult-to-treat mental health disorders by promoting...

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease

Second biotechnology company to potentially out-license novel compounds from Enveric’s portfolio of assets with possible significant milestone payments and royalties Enveric Biosciences (NASDAQ:...

Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets

Patents extend compositional protection to proprietary compounds Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0599-6.885057471260.870.8850.81056540.82975847CS
4-0.1199-12.89247311830.931.030.78312443900.95741078CS
12-0.8499-51.19879518071.661.90.78317822151.19527191CS
26-0.5799-41.71942446041.392.920.64924183981.33025534CS
52-3.2599-80.09582309584.076.980.64915711792.09613676CS
156-1.8699-69.77238805972.6814.870.155116539991.96917424CS
260-4.9899-86.03275862075.814.870.155120478822.58391084CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
AKANAkanda Corporation
$ 4.07
(70.29%)
39.11M
TKLFYoshitsu Company Ltd
$ 0.3496
(53.33%)
84.5M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M
MRUSMerus NV
$ 59.92
(35.97%)
6.91M
VSTMVerastem Inc
$ 4.0901
(-66.42%)
19.68M
TOIIWOncology Institute Inc
$ 0.0443
(-55.61%)
280.55k
SNSESensei Biotherapeutics Inc
$ 0.7912
(-45.43%)
1.41M
GNLXGenelux Corporation
$ 2.61
(-43.26%)
3.32M
AUVIApplied UV Inc
$ 0.32
(-33.33%)
5.18M
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
GWAVGreenwave Technology Solutions Inc
$ 0.0843
(-4.85%)
428.98M
NCPLNetcapital Inc
$ 0.20
(14.42%)
191.35M
HLTHCue Health Inc
$ 0.0931
(-1.27%)
160.21M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M

ENVB Discussion

View Posts
Monksdream Monksdream 2 weeks ago
Mighty fluffy press release
👍️0
Awl416 Awl416 2 weeks ago
Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
👍️0
Awl416 Awl416 2 months ago
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
👍️0
Monksdream Monksdream 2 months ago
ENVB under $2
👍️0
glenn1919 glenn1919 3 months ago
ENVB.........................................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783
👍️0
Invest-in-America Invest-in-America 3 months ago
ENVB: The Pro's are now workin' on their THIRD-NICE-FLIP behind this (easy money) puppy today!!! (I.e., one 100%-profit flip in the Pre-M, & now TWO circa 25-to-30%-profit flips in the Open-M!!! Yet STUPID traders cry about "Wash Trades". L.M.M.F.A.O.!!!!!)
👍️0
Invest-in-America Invest-in-America 3 months ago
ENVB: Heck, "Wash-Trades" keep those PROFITS nice & CLEAN!!!!
👍️0
Monksdream Monksdream 3 months ago
Wash trade du jour
👍️0
Invest-in-America Invest-in-America 3 months ago
ENVB: I'm buyin' latte's for everyone later today, up on the MOON!!!
👍️0
Invest-in-America Invest-in-America 3 months ago
ENVB: 3-bagger from here, whether anybody likes it or not!! (Just the way it goes, these days!!)
👍️0
TimeFades TimeFades 3 months ago
Nasty trap
👍️0
TimeFades TimeFades 3 months ago
Short
👍️0
tw0122 tw0122 3 months ago
The term sheets further provide that, Enveric could be eligible to receive future development and sales milestone payments and execution fees for the three licenses, which in total could add up to $200 million, assuming certain conditions are met, including receiving approval for the investigational new drug (IND) applications and completing Phases I through III testing of the licensed products. Royalty rates on each of the three licenses could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria. The compound classes under the term sheets come from two of the seven portfolios of preclinical molecules that Enveric recently unveiled as available for out-licensing. Numerous molecules and classes remain available for additional out-licensing opportunities.

“Patients living with serious mental health conditions have seen insufficient innovation for far too long, and we are excited for the opportunity to progress several of the novel compounds generated using our drug discovery engine,” said Joseph Tucker, Ph.D., Director and CEO of Enveric. “We look forward to working with our partner, and we are confident in their leadership and capabilities to work on further developing these drug candidates to advance treatment options for patients. Ultimately, we believe the definitive licensing agreements, once negotiated and finalized, could represent an excellent potential source of revenue for Enveric, and could demonstrate the value creation from Enveric’s discovery capabilities and proprietary PsyAI™ and Psybrary™ platforms, which have already generated an impressive library of compounds targeting a variety of CNS disorders.”
👍️0
glenn1919 glenn1919 3 months ago
ENVB.........................................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 3 months ago
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
👍️0
I-Glow I-Glow 8 months ago
What's the patent application number?

IG
👍️0
Awl416 Awl416 10 months ago
4.96 to 3 blink of any eye
👍️0
Triple nickle Triple nickle 1 year ago
7.52 easy
👍️0
Jess070283 Jess070283 1 year ago
$4-$5.75. Done for the day. Wooo
👍️0
Awl416 Awl416 1 year ago
Enveric Biosciences Receives Notice of Allowance From USPTO for C4-Carboxylic Acid-Substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug
👍️0
PennyPusher786 PennyPusher786 1 year ago
Nice flipper
👍️0
Triple nickle Triple nickle 1 year ago
Ok it cooled off
Five dollar run
👍️0
PennyPusher786 PennyPusher786 1 year ago
Now a Rug Pooool candidate lol... Now it's too dangerous... It can run 4+ but it can dump too as seen from 4.20s to 3.20s in all of 15 seconds
👍️0
PennyPusher786 PennyPusher786 1 year ago
Another rip or another dump, only the devil knows
👍️0
PennyPusher786 PennyPusher786 1 year ago
Good call. Ran to 4.20s and dumped to 3.20s
👍️0
Triple nickle Triple nickle 1 year ago
I’m out
👍️0
surf1944 surf1944 1 year ago
https://stockcharts.com/h-sc/ui?s=envb&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/envb/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/envb/opinion

Open gap at $1.52
👍️0
PennyPusher786 PennyPusher786 1 year ago
There's another pullback
👍️0
Invest-in-America Invest-in-America 1 year ago
Ooooooops!! (iHub posting error, glitch, etc.).
👍️0
Invest-in-America Invest-in-America 1 year ago
ENVB: I'm workin' on an ANSWER to your question right now, Sir. (See my 'Chart' on this, below.)

👍️0
TheFinalCD TheFinalCD 1 year ago
WALL @ 3.50 JUST TAKEN OUT
👍️0
PennyPusher786 PennyPusher786 1 year ago
Anyone smell a bait and pull? Lol or do we forsee $5- 6
👍️0
Invest-in-America Invest-in-America 1 year ago
ENVB: See ya-all up on the MOON later, Folks!!
👍️0
PennyPusher786 PennyPusher786 1 year ago
Same. I expect pullbacks and runs if the volume stays consistent.. which means mass flipping
👍️0
Triple nickle Triple nickle 1 year ago
Watching
👍️0
PennyPusher786 PennyPusher786 1 year ago
This could run 5 - 6 today.
👍️0
Triple nickle Triple nickle 1 year ago
Sell down now
👍️0
Awl416 Awl416 1 year ago
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
👍️0
DDA DDA 2 years ago
The RS already took place. Don't understand why my post would need to ve deleted
👍️0
Klinsmann Klinsmann 2 years ago
But gonna be a nice entry soon imo
👍️0
Roadtojourney Roadtojourney 2 years ago
Rs and dilution followed right after wow??
👍️0
DDA DDA 2 years ago
Reverse split just anounced
👍️0
BoilerRoom BoilerRoom 2 years ago
What are other biotech stocks I’m not familiar with this sector. Appreciate your feedback MASTERULTRA you seem to know about these.
👍️0
MASTERULTRA MASTERULTRA 2 years ago
Seriously, WTF!!! this company should be trending higher due to 04/20...

I fucking hope the people who short this or manipulate this gets Karma.
👍️0
DallasInvest DallasInvest 2 years ago
The douche canoe Dj front load of the day lol
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 2 years ago
$ENVB Added..looks like interest building here..
👍️0
kzivann kzivann 2 years ago
Back on watch .. Bottom or how much lower?

ENVB
👍️0
The ELTP King The ELTP King 2 years ago
Agreed.

This company is a total loser with zero revenue.

Absolute embarrassment.

New CFO Carter Ward ran this company into the ground in just 9 months.

Delist imminent or reverse split.





👍️0
NASDAQ2020 NASDAQ2020 2 years ago
Delist imminent or reverse split.
👍️0
Jake L Jake L 3 years ago
ENVB - Thursday Rundown, Friday Expectations

👍️0

Your Recent History

Delayed Upgrade Clock